Eli Lilly and Co (LLY) Analysts See $1.03 EPS; 12 Analysts Are Bullish Axa SA (EPA:CS) Last Week

June 20, 2017 - By marketbeat

Among 18 analysts covering AXA (EPA:CS), 12 have Buy rating, 0 Sell and 6 Hold. Therefore 67% are positive. AXA had 50 analyst reports since August 4, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Wednesday, September 21 by Bankhaus Lampe. Credit Suisse upgraded Axa SA (EPA:CS) on Tuesday, January 17 to “Outperform” rating. Robert W. Baird upgraded the stock to “Outperform” rating in Thursday, December 8 report. Independent Research maintained the stock with “Hold” rating in Wednesday, November 9 report. On Friday, December 23 the stock rating was maintained by UBS with “Neutral”. Independent Research maintained the shares of CS in report on Tuesday, May 31 with “Hold” rating. The stock of Axa SA (EPA:CS) earned “Buy” rating by Citigroup on Saturday, January 23. The company was upgraded on Tuesday, July 19 by Jefferies. Goldman Sachs upgraded Axa SA (EPA:CS) on Tuesday, December 8 to “Buy” rating. Independent Research maintained the shares of CS in report on Tuesday, July 5 with “Hold” rating. See Axa SA (EPA:CS) latest ratings:

28/02/2017 Broker: DZ BANK Rating: Buy Upgrade
24/02/2017 Broker: S&P Research Rating: Buy New Target: €26.00 Upgrade
24/02/2017 Broker: Kepler Cheuvreux Rating: Buy New Target: €27.50 Upgrade
14/02/2017 Broker: Deutsche Bank Rating: Hold New Target: €25.20 Maintain
17/01/2017 Broker: Credit Suisse Rating: Outperform New Target: €28.50 Upgrade
13/01/2017 Broker: Independent Research Rating: Hold New Target: €25.00 Maintain
13/01/2017 Broker: Kepler Cheuvreux Rating: Buy New Target: €27.50 Upgrade
30/12/2016 Broker: DZ BANK Rating: Buy Upgrade
29/12/2016 Broker: UBS Rating: Neutral New Target: €22.70 Maintain
24/12/2016 Broker: DZ BANK Rating: Buy Upgrade

Analysts expect Eli Lilly and Co (NYSE:LLY) to report $1.03 EPS on July, 25 before the open.They anticipate $0.17 EPS change or 19.77% from last quarter’s $0.86 EPS. LLY’s profit would be $1.13B giving it 19.99 P/E if the $1.03 EPS is correct. After having $0.98 EPS previously, Eli Lilly and Co’s analysts see 5.10% EPS growth. The stock increased 0.56% or $0.46 during the last trading session, reaching $82.34. About shares traded. Eli Lilly and Co (NYSE:LLY) has risen 4.70% since June 20, 2016 and is uptrending. It has underperformed by 12.00% the S&P500.

Eli Lilly and Company is engaged in drug manufacturing business. The company has market cap of $90.66 billion. The Firm discovers, develops, makes and markets products in two divisions: human pharmaceutical products and animal health products. It has a 39.99 P/E ratio. The Company’s human pharmaceutical business segment sells medicines, which are discovered or developed by its scientists.

Investors sentiment decreased to 0.97 in 2016 Q4. Its down 0.11, from 1.08 in 2016Q3. It worsened, as 84 investors sold Eli Lilly and Co shares while 380 reduced holdings. 103 funds opened positions while 348 raised stakes. 809.72 million shares or 0.51% more from 805.63 million shares in 2016Q3 were reported. Woodstock has invested 0.06% of its portfolio in Eli Lilly and Co (NYSE:LLY). Sumitomo Life Insurance owns 33,071 shares for 0.35% of their portfolio. Peak6 Investments L P, Illinois-based fund reported 22,345 shares. Intersect Ltd Com owns 8,514 shares. Profund Advsr Ltd Liability Corp invested in 0.19% or 55,478 shares. Bankshares Of Nova Scotia holds 0.01% or 22,073 shares in its portfolio. Royal Bancorp Of Scotland Grp Incorporated Public Limited Company reported 1.34% of its portfolio in Eli Lilly and Co (NYSE:LLY). Hyman Charles D reported 0.06% in Eli Lilly and Co (NYSE:LLY). State Board Of Administration Of Florida Retirement Sys invested in 0.32% or 1.42 million shares. Kcm Advsr Ltd Company owns 64,025 shares or 0.32% of their US portfolio. Highland Cap Mgmt Ltd holds 0.08% of its portfolio in Eli Lilly and Co (NYSE:LLY) for 13,139 shares. Nbt National Bank N A Ny has 11,812 shares for 0.15% of their portfolio. Int Group Inc invested in 313,080 shares. Ing Groep Nv holds 105,171 shares or 0.15% of its portfolio. Friess Assocs accumulated 120,000 shares.

Since February 1, 2017, it had 0 insider buys, and 9 selling transactions for $59.49 million activity. Shares for $17.02M were sold by LILLY ENDOWMENT INC on Wednesday, February 1. Another trade for 25,000 shares valued at $2.07M was made by Conterno Enrique A on Thursday, May 4. $1.16M worth of Eli Lilly and Co (NYSE:LLY) shares were sold by Zulueta Alfonso G. Another trade for 22,833 shares valued at $1.83M was sold by Harrington Michael J. $153,482 worth of stock was sold by Barnes Melissa S on Monday, June 12. $155,040 worth of Eli Lilly and Co (NYSE:LLY) shares were sold by Zakrowski Donald A. Rice Derica W sold $861,085 worth of stock or 11,162 shares.

Among 17 analysts covering Eli Lilly and Company (NYSE:LLY), 13 have Buy rating, 1 Sell and 3 Hold. Therefore 76% are positive. Eli Lilly and Company had 49 analyst reports since July 23, 2015 according to SRatingsIntel. Barclays Capital maintained the shares of LLY in report on Friday, April 7 with “Overweight” rating. The firm has “Overweight” rating given on Tuesday, December 1 by Barclays Capital. The stock of Eli Lilly and Co (NYSE:LLY) earned “Buy” rating by Jefferies on Tuesday, May 30. The rating was maintained by Jefferies with “Buy” on Friday, September 18. The stock of Eli Lilly and Co (NYSE:LLY) earned “Outperform” rating by Credit Suisse on Friday, October 9. The stock of Eli Lilly and Co (NYSE:LLY) has “Buy” rating given on Friday, April 7 by Citigroup. The rating was maintained by Jefferies on Thursday, July 14 with “Buy”. The firm earned “Overweight” rating on Friday, December 16 by Morgan Stanley. The stock has “Neutral” rating by Atlantic Securities on Friday, November 25. The firm has “Buy” rating given on Thursday, August 27 by Berenberg.

AXA SA is a holding company engaged in the business of financial protection. The company has market cap of 58.93 billion EUR. The Company’s divisions include Life & Savings, Property & Casualty, International Insurance, Asset Management, Banking and Holding companies. It has a 9.8 P/E ratio. The Life & Savings segment’s products include a range of investment and savings products, as well as Protection and Health products.

About 1.72M shares traded. Axa SA (EPA:CS) has risen 6.69% since June 20, 2016 and is uptrending. It has underperformed by 10.01% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: